Page last updated: 2024-11-06

2,4-dihydroxyphenylacetic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

2,4-dihydroxyphenylacetic acid, also known as homogentisic acid, is an organic compound that plays a crucial role in the metabolism of tyrosine. It is an intermediate in the catabolism of tyrosine, a process that converts tyrosine to fumarate and acetoacetate. The enzyme homogentisate 1,2-dioxygenase catalyzes the conversion of homogentisic acid to maleylacetoacetate, a key step in this metabolic pathway. Genetic defects in this enzyme can lead to the accumulation of homogentisic acid in the body, resulting in a condition called alkaptonuria. This condition is characterized by the excretion of homogentisic acid in urine, which turns dark upon standing due to oxidation. Homogentisic acid is also known to be involved in various biological processes, including antioxidant activity, anti-inflammatory effects, and potential anticancer properties. Research on homogentisic acid focuses on understanding its metabolic pathways, exploring its potential therapeutic applications, and developing strategies for managing alkaptonuria.'

Cross-References

ID SourceID
PubMed CID69199
SCHEMBL ID156238
MeSH IDM0152770

Synonyms (18)

Synonym
2,4-dihydroxyphenylacetic acid
2-(2,4-dihydroxyphenyl)acetic acid
614-82-4
A833257
benzeneacetic acid, 2,4-dihydroxy-
unii-lhb7i6aa5x
homo-beta-resorcylic acid
einecs 210-397-4
lhb7i6aa5x ,
2-methyl-3-(trifluoromethyl)benzylbromide
AKOS022184907
SCHEMBL156238
DTXSID1060635
FSQDURCMBCGCIK-UHFFFAOYSA-N
2,4-dihydroxybenzeneacetic acid
dioxyphenylacetic acid
FS-8876
EN300-1692688
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (33.33)18.7374
1990's2 (33.33)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.47

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.47 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.42 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.47)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]